CareDx (CDNA) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to CareDx (CDNA) Misses Q1 EPS by 6c

CareDx, Inc. Reports First Quarter 2016 Financial Results

May 6, 2016 7:30 AM EDT

BRISBANE, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today reported financial results for the first quarter ended March 31, 2016.

Recent Highlights

Total revenue for the first quarter of 2016 was $6.6 millionCompleted acquisition of Allenex AB, creating an international transplant diagnostics companyIncreased AlloMap patient results volume by 8% in the first quarter of 2016 compared with the same period in 2015Built further momentum on AlloMap Variability with 41... More